Feedback / Questions
OPTF01 - Optieum Biotechnologies
https://www.prnewswire.com/news-releases/cellipont-bioservices-and-optieum-biotechnologies-partner-to-advance-cgmp-manufacturing-of-groundbreaking-car-t-therapy-for-glioblastoma-302449468.html
May 8, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next